• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Comparison of GI Side Effects of Antidepressants

Comparison of GI Side Effects of Antidepressants

August 3, 2021
Jesus Ligot, MD.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Jesus Ligot, MD. Dr. Ligot has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

REVIEW OF: Oliva V et al, Prog Neuropsychopharmacol Biol Psychiatry 2021;109:110266

TYPE OF STUDY: Meta-analysis of placebo-controlled trials

Antidepressants often cause gastrointestinal (GI) side effects, but it’s not clear which ones are the worst actors. A recent meta-analysis helps to clarify the picture.

The investigators searched the literature and located 304 randomized, placebo-controlled trials with information on GI side effects on 15 antidepressants (including SSRIs, SNRIs, bupropion, and mirtazapine). Nausea and vomiting was the most common side effect, with the worst five antidepressants being duloxetine (odds ratio [OR] 4.33), vortioxetine (OR 4.28), levomilnacipran (OR 3.81), venlafaxine (OR 3.52), and desvenlafaxine (OR 3.51). Only mirtazapine was not associated with nausea and vomiting, which is consistent with its mechanism of action. The risk of nausea and vomiting was dose dependent for citalopram and escitalopram and became more pronounced at dosages above 40 mg/day for citalopram and 10 mg/day for escitalopram.

Constipation occurred on 10 antidepressants, with levomilnacipran (OR 3.41), desvenlafaxine (OR 3.41), and duloxetine (OR 2.58) being the top three. Vortioxetine had a dose-dependent risk of constipation at dosages above 20 mg/day (which is also the maximum recommended dose). Only five antidepressants were associated with diarrhea: sertraline (OR 2.33), fluvoxamine (OR 2.29), escitalopram (OR 1.91), citalopram (OR 1.64), and duloxetine (OR 1.60).

Other GI side effects were also examined and are summarized in the table.

TCPR’s Take
While most antidepressants can cause GI side effects, it appears that SNRIs and vortioxetine are the most likely to cause both nausea and constipation. True to its reputation, sertraline caused the most diarrhea. Paroxetine was associated with anorexia, suggesting this medication may have opposite effects in different patients, as other studies have associated it with weight gain. Surprisingly, the two antidepressants associated with weight loss—bupropion and fluoxetine—did not decrease patients’ appetite in this ­analysis.
Table: GI Side Effects on Modern Antidepressants

Table: GI Side Effects on Modern Antidepressants

(Click to view full-sized PDF.)

 


Podcasts iconTo learn more, listen to our 8/9/21 podcast, “Treating Nausea on Psych Meds.” Search for “Carlat” on your podcast store.


General Psychiatry
KEYWORDS antidepressants depression depressive_disorder free_articles mirtazapine side-effects snris ssris
    Jesus Ligot, MD.

    More from this author
    www.thecarlatreport.com
    Issue Date: August 3, 2021
    SUBSCRIBE NOW
    Table Of Contents
    ECT Worked: Now What?
    Turning Nightmares Into Dreams
    Lemborexant and Sleep Architecture in the Elderly
    Comparison of GI Side Effects of Antidepressants
    CME Post-Test - Therapy, TCPR, August 2021
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2603816031.jpg
      General Psychiatry

      A Scam for Every Woman, Child, and Man: Part 2

      1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.